[1] BMI India pharmceutical and healthcare report 2011 [EB/OL].[2011- 06-01].http://store.businessmonitor.com/pharma/india_pharmace- 2 uticals_and_healthcare_report. [2] Deepa Arora.Pharmacovigilance obligations of the pharmaceutical companies in India[J]. Indian Journal of Pharmacology, 2008, 40(2).Supplement.13-16. [3] The importance of pharmacovigilance：safety monitoring of medicinal products[M]. Geneva： World Health Organization,2002,7. [4] Ashish Kumar Srivastava, GarimaGupta,Dr.S.K.Mishra, et al. Pharmacovigilance: A Global and Indian perspective[J]. Journal of Pharmacy Research, 2010,3(5):1034-1048. [5] P Biswas, AK. Setting standards for proactive pharmacovigilance in India:the way ahead[J].Indian Journal of Pharmacology, 2007, 39:124-128. [6] CDSCO.Pharmacovigilance Programme of India (PvPI) for Assuring Drug Safety [EB/OL].[2010-7-14]. http://cdsco.nic.in/pharm- acovigilance.htm. [7] India's Central Drugs Standard Control Organization (CDSCO) [EB/ OL].http://www.pacificbridgemedical.com/countries/india/cdsco. [8] PvPI.SUSPECTED ADVERSE DRUG REACTION REPORTING FORM [EB/OL].[2010-7-14].http://cdsco.nic.in/pharmacovigilance.htm. [9] PvPI.STANDARD OPERATING PROCEDURE-Causality assessment of ADR reports[M].National Coordinating Center,2011. [10] PvPI.STANDARD OPERATING PROCEDURE-Quality assurance of ADR reports[M].National Coordinating Center,2011.
